EMA scales back transparency initiatives because of workload

被引：4
作者：
Doshi, Peter
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2018年 / 362卷
关键词：
D O I：
10.1136/bmj.k3513
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 13 条
[1]   Open data 5 years on: a case series of 12 freedom of information requests for regulatory data to the European Medicines Agency [J].
Doshi, Peter ;
Jefferson, Tom .
TRIALS, 2016, 17
[2]   Transparency Interrupted: The Curtailment of the European Medicines Agency's Policy on Access to Documents [J].
Doshi, Peter .
JAMA INTERNAL MEDICINE, 2013, 173 (21)
[3]   The First 2 Years of the European Medicines Agency's Policy on Access to Documents: Secret No Longer [J].
Doshi, Peter ;
Jefferson, Tom .
JAMA INTERNAL MEDICINE, 2013, 173 (05) :380-382
[4]  
European Medicines Agency, 2018, ANN ANN REP EUR MED
[5]  
European Medicines Agency, 2018, EMA6302462017
[6]  
European Medicines Agency, ACC TO DOC
[7]  
European Medicines Agency, BREX PREP EMA FURTH
[8]   Opening up data at the European Medicines Agency [J].
Gotzsche, Peter C. ;
Jorgensen, Anders W. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[9]   Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials [J].
Hodkinson, Alex ;
Gamble, Carrol ;
Smith, Catrin Tudur .
TRIALS, 2016, 17
[10]  
Jefferson T, 2012, COCHRANE DB SYST REV, V1
12